GlassScriptPhysician profile
Kevin W Dow
NPI 1184826828
$20,104.67
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $48.85 · 2021: $190 · 2024: $23.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $19,709.83 | 2019-2020 | |
| Smith+Nephew, INC. | $128.51 | 2021 | |
| Integra Lifesciences Corporation | $100.04 | 2019-2021 | |
| Depuy Synthes Sales INC. | $92.34 | 2019 | |
| Paragon 28, INC. | $26.54 | 2019 | |
| Aroa Biosurgery Incorporated | $23.83 | 2024 | |
| Horizon Therapeutics Plc | $23.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Dow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.